- Home
- QNCX vs NYC Comparison
QNCX vs NYC Comparison
Compare QNCX & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QNCX | NYC |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.5M | 19.9M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | QNCX | NYC |
|---|---|---|
| Price | $29.44 | $6.45 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.2K | ★ 25.8K |
| Earning Date | 04-10-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 85.28 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $56.73 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.08 | $5.82 |
| 52 Week High | $35.41 | $13.97 |
Technical Indicators
Market Signals| Indicator | QNCX | NYC |
|---|---|---|
| Relative Strength Index (RSI) | 46.63 | 37.30 |
| Support Level | $0.82 | $5.97 |
| Resistance Level | $35.38 | $8.89 |
| Average True Range (ATR) | 2.07 | 0.39 |
| MACD | -1.04 | 0.05 |
| Stochastic Oscillator | 4.41 | 39.72 |
Price Performance
Historical ComparisonAbout QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.